Exon

Type: Keyphrase
Name: Exon
First reported 7 hours ago - Updated 7 hours ago - 1 reports

Top 10 From IMTS 2014

This year’s has shown optimistic numbers, and the Manufacturing.net staff was part of the thundering traffic cruising through McCormick Place in Chicago. There was more to see than any normal human could take in within the six-day show – 1,900 exhibitors ... [Published Industrial Distribution - 7 hours ago]
First reported 14 hours ago - Updated 14 hours ago - 1 reports

Non-human mammalian animal model for type 2 diabetes

The present invention provides a non-human mammalian animal model for type 2 diabetes, which spontaneously develops a pathological condition similar to human type 2 diabetes of a non-obese type seen in some Japanese people. The non-human mammalian animal ... [Published Free Patents Online - 14 hours ago]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Novel Mutations in FKBP10 and PLOD2 Cause Rare Bruck Syndrome in Chinese Patients

by Peiran Zhou, Yi Liu, Fang Lv, Min Nie, Yan Jiang, Ou Wang, Weibo Xia, Xiaoping Xing, Mei LiBruck syndrome (BS) is an extremely rare form of osteogenesis imperfecta characterized by congenital joint contracture, multiple fractures and short stature. ... [Published Plosone.org - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

RNA breakthrough

Chinese scientists have made a breakthrough on RNA research, by clarifying the mechanism of complementary sequence-mediated exon circularization biogenesis for the first time, the Shanghai Institutes for Biological Sciences of the Chinese Academy of Sciences ... [Published Global Times - Sep 19 2014]
Entities: RNA, Exon, RNA Splicing, INTRON
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Mandatory Extended RAS Testing for mCRC

Extended RAS Mutations and Anti-EGFR Monoclonal Antibody Survival Benefit in Metastatic Colorectal Cancer: a Meta-analysis of Randomized Controlled TrialsSorich MJ, Wiese MD, Rowland A, Kichenadasse G, McKinnon RA, Karapetis CSAnn Oncol . 2014 Aug 12. ... [Published General Medicine eJournal - Sep 19 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

First Report of a Deletion Encompassing an Entire Exon in the Homogentisate 1,2-Dioxygenase Gene Causing Alkaptonuria

by Mohammad Zouheir Habbal, Tarek Bou-Assi, Jun Zhu, Renius Owen, Farid F. ChehabAlkaptonuria is often diagnosed clinically with episodes of dark urine, biochemically by the accumulation of peripheral homogentisic acid and molecularly by the presence ... [Published Plosone.org - Sep 18 2014]
First reported Sep 17 2014 - Updated Sep 18 2014 - 1 reports

Prosensa announces commencement of re-dosing of drisapersen in North America in patients with Duchenne muscular dystrophy

Leiden, The Netherlands, Sept. 17, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. ( NASDAQ: RNA ), the biopharmaceuticalcompany focusing on RNA-modulating therapeutics for rare diseaseswith high unmet need, today announced that a comprehensive progra ... [Published The CW44 Tampa Bay - Sep 17 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Key Regulator of Cancer-Inducing Alternative Splicing Identified

Image: Alternative splicing produces two protein isoforms (Photo courtesy of Wikimedia Commons).Cancer researchers have identified the splicing factor RBM4 (RNA-binding protein 4) as a key determinant in processes that prevent tumor development and s ... [Published Biotech Daily - Sep 18 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Hitachi : Patent Issued for Method and Kit for Detection of Microsatellite Instability-Positive Cell

By a News Reporter-Staff News Editor at Cancer Weekly -- According to news reporting originating from Alexandria, Virginia , by NewsRx journalists, a patent by the inventors Takahashi, Ryosuke ( Kawagoe , JP); Nagai, Keiichi (Higashiyamato, JP), filed ... [Published 4 Traders - Sep 18 2014]
First reported Sep 17 2014 - Updated Sep 18 2014 - 1 reports

New Data from Institute of Microbiology Illuminate Findings in Supramolecular Research (Intrinsically disordered enamel matrix protein ameloblastin...

New Data from Institute of Microbiology Illuminate Findings in Supramolecular Research (Intrinsically disordered enamel matrix protein ameloblastin forms ribbon-like supramolecular structures via an N-terminal segment encoded by exon 5) ( ...)By a News ... [Published HispanicBusiness.com - Sep 17 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Researchers at Wonkwang University Target Molecular Medicine (Alternative promoter activation leads to the expression of a novel human lysyl oxidase...

Researchers at Wonkwang University Target Molecular Medicine (Alternative promoter activation leads to the expression of a novel human lysyl oxidase variant that functions as an amine oxidase) (Alternative promoter activation leads to the ...)By a News ... [Published 4 Traders - Sep 17 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Cell death pre-mRNA-encoding DNA

Methods and products for the repair of genetically defective DNA in the region of a mutated exon, for the specific destruction of tumor cells, and for the identification of naturally trans-spliced RNA. The methods inter alia are based on the utilization ... [Published PharmCast - Sep 17 2014]

Quotes

The MIT/ICBP siRNA Database http:(//)web.mit.edu/sirna/-- "The MIT [Massachusetts Institute of Technology]/ICBP [Integrative Cancer Biology Program] siRNA Database is a university-wide effort to catalog these experimentally validated reagents and make that information available to other researchers, both within and outside the MIT community. (Massachusetts Institute of Technology)."
"FIG. 1 shows the primers and probes used in the amplification and detection of BRAF mutations."
"I like the unique personality and feel of New Orleans" said Hernandez, who hopes to get acquainted with members of the local Latino community. The Kezic Gallery, at 646 Tchopitoulas St...
...we rely on collaboration with strong partners for the clinical development and commercialization of our compounds," noted Hoerr in a statement. "Cancer immunotherapy represents one of the biggest innovations in cancer treatment of recent times and we are delighted to now be working with Boehringer Ingelheim. The out-licensing and clinical development of our promising therapeutic vaccine CV9202 represents the logical next step in developing - novel treatment options for cancer patients and the significant commitment from Boehringer Ingelheim underscores the relevance of the mRNA technology."

More Content

All (260) | News (208) | Reports (0) | Blogs (50) | Audio/Video (0) | Fact Sheets (0) | Press Releases (2)
sort by: Date | Relevance
Top 10 From IMTS 2014 [Published Industrial Distribution - 7 hours ago]
Non-human mammalian animal model for type 2 dia... [Published Free Patents Online - 14 hours ago]
Patient-Contributed Tumor Genetics Data: A Path... [Published American Journal of Managed Care - Sep 22 2014]
Recombinant vectors [Published PharmCast - Sep 21 2014]
Markers for determination of patient responsive... [Published PharmCast - Sep 21 2014]
Novel Mutations in FKBP10 and PLOD2 Cause Rare ... [Published Plosone.org - Sep 19 2014]
RNA breakthrough [Published Global Times - Sep 19 2014]
Mandatory Extended RAS Testing for mCRC [Published General Medicine eJournal - Sep 19 2014]
First Report of a Deletion Encompassing an Enti... [Published Plosone.org - Sep 18 2014]
Genetic Features of Late Onset Primary Hemophag... [Published Plosone.org - Sep 18 2014]
"Methods, Primers, Probes and Kits Useful for t... [Published 4 Traders - Sep 18 2014]
Natalia Hernandez is new assistant head of Isid... [Published Times Picayune / NOLA.com - Sep 18 2014]
Boehringer pairs its lung cancer drug with a va... [Published FierceBiotech - Sep 18 2014]
Boehringer Ingelheim and CureVac announce colla... [Published Industrial Info Financials - Sep 18 2014]
Boehringer Ingelheim and CureVac announce colla... [Published A.M. Best - Sep 18 2014]
Key Regulator of Cancer-Inducing Alternative Sp... [Published Biotech Daily - Sep 18 2014]
Hitachi : Patent Issued for Method and Kit for ... [Published 4 Traders - Sep 18 2014]
REGENERON PHARMACEUTICALS : Patent Application ... [Published 4 Traders - Sep 18 2014]
New Data from Institute of Microbiology Illumin... [Published Industrial Info Financials - Sep 18 2014]
New Data from Institute of Microbiology Illumin... [Published HispanicBusiness.com - Sep 17 2014]
Researchers at Wonkwang University Target Molec... [Published 4 Traders - Sep 17 2014]
Aberrant methylation of tRNAs links cellular st... [Published EMBO Journal - Sep 17 2014]
Findings in the Area of Prostate Research Repor... [Published 4 Traders - Sep 17 2014]
Prosensa announces commencement of re-dosing of... [Published The CW44 Tampa Bay - Sep 17 2014]
Oxford Gene Technology Ltd. Presents The Latest... [Published BioSpace - Sep 17 2014]
Confirmation of Cause and Manner of Death Via a... [Published Insurance News Net - Sep 17 2014]
Patent Issued for Uses of NOGO-A Inhibitors and... [Published 4 Traders - Sep 17 2014]
OGT to highlight NGS and FISH methods for tumou... [Published News-Medical.Net - Sep 17 2014]
Why Sarepta Therapeutics Inc. Stock Soared By 1... [Published Motley Fool Discussion Boards - Sep 17 2014]
Cell death pre-mRNA-encoding DNA [Published PharmCast - Sep 17 2014]
1 2 3 4 5 6 7 8 9
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
“New” Features of the iPhone 6 and Apple Watch [Published Security Bloggers Network - Sep 15 2014]
 September 15, 2014 The iPhone 6 and the Apple Watch have most likely been blowing up your Facebook and Twitter news feeds, and it will most likely only get worse when the devices are actually available for purchase. The iPhone 6 unlike any other smartphone ...
News from ACTRIMS/ECTRIMS 2014 Pharma in the hu... [Published Multiple Sclerosis Research - Sep 14 2014]
#MS research Pharma led #remyelination trials ongoing RR Wang, Y Chen, T Guo, W Zhen, TB Guo, RY Zhao,AA Liu1, JP Rubio, D Krull, J Lu, M Song, P Thompson,S Wang1, JC Richardson.Histamine H3 receptor negatively regulates oligodendrocyte differentiation ...
Agilent Technologies Introduces Next-Generation... [Published EON Science - Sep 02 2014]
SANTA CLARA, Calif.--(EON: Enhanced Online News)--Agilent Technologies Inc. (NYSE: A) today introduced ClearSeq AML, the first product in the ClearSeq line of next-generation cancer research panels, which targets 48 selected exons in 20 of the most commonly ...
Agilent Technologies Introduces Next-Generation... [Published Business Wire Science: Science News - Sep 02 2014]
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced ClearSeq AML, the first product in the ClearSeq line of next-generation cancer research panels, which targets 48 selected exons in 20 of the most commonly mutated ...
Agilent Technologies Introduces Next-Generation... [Published Business Wire Health News - Sep 02 2014]
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced ClearSeq AML, the first product in the ClearSeq line of next-generation cancer research panels, which targets 48 selected exons in 20 of the most commonly mutated ...
1 2 3 4 5 6 7 8 9 10

Press Releases

sort by: Date | Relevance
Prosensa Announces 2nd Quarter 2014 Financial R... [Published GlobeNewswire: Acquisitions News - Aug 12 2014]
Prosensa Awarded $200,000 Research Grant from PPMD [Published GlobeNewswire: Advertising News - Jun 27 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.